[Efficacy of adding transcranial electrical stimulation to monopharmacotherapy in post-COVID syndrome with chronic fatigue and cognitive decline].
Rubel AD, Gumenyuk LN, Bobrik YV · 2025 · Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury; 2025
Study findings
The authors favored adding transcranial electrical stimulation to Cortexin for post-COVID fatigue and cognitive outcomes.
- Population and setting
- 150 patients with post-COVID fatigue and cognitive decline; 75 per group
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Both groups received Cortexin; this comparison tests added stimulation, not Cortexin efficacy versus no treatment.
- The abstract does not supply sufficient numerical between-group results to calculate an effect size.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed record and abstract checked. Full methods and risk of bias have not been independently assessed.
Recorded source-check date: 2026-10-06. This date does not imply a completed systematic review.
Citation and original source
Original source: Rubel AD, Gumenyuk LN, Bobrik YV. [Efficacy of adding transcranial electrical stimulation to monopharmacotherapy in post-COVID syndrome with chronic fatigue and cognitive decline]. Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury; 2025 2025.
Molekul research summary: https://molekul.io/research/recent-41537614. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry